Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Europe open: Shares up on rate cut bets; Merck tanks on MS trial failure

(Sharecast News) - European shares made a strong start on Wednesday as investors started to bet on interest rate cuts and shrugged off an unexpected slump in German factory orders, while Merck shares tanked after a multiple-sclerosis drug failed in late-stage trials. The pan-European Stoxx 600 index was up 0.36% in early deals at 469.27 with all major regional bourses higher.

"Yesterday was all about markets fretting that the Fed would not cut rates anytime soon. Today they are back to believing that they will. Having pushed US bond yields all the way from 3.3% up to 5% in recent months, 10-year US bonds have been fighting back in recent weeks, with yields now back down to 4.2%," said Steve Clayton, head of equity funds at Hargreaves Lansdown.

"We're in the phoney war stage of the economic cycle. The action last night was really all in the bond market, with stocks little changed on Wall Street. But Asian markets rebounded from yesterday's weakness leaving things pretty much where they were."

In economic news, German factory orders unexpectedly slumped in October, according to figures released on Wednesday by Destatis.

Orders fell by 3.7% on the month following an upwardly-revised 0.7% increase in September, coming in weaker than expectations for a 0.2% jump.

Destatis said much of the decline was due to the performance of the manufacture of machinery and equipment sector, where new orders tumbled 13.5%.

By contrast, there was a 20.2% rise in new orders in the manufacture of other transport equipment such as aircraft, ships, trains, etc. This was thanks to large-scale orders received in this sector.

On the equities front, Merck shares were down 18% after phase III trials of its promising evobrutinib drug failed to show the required efficacy for treatment of multiple-sclerosis.

Tobacco and nicotine giant British American Tobacco was in the red after scaling back its expectations for organic growth this year and unveiling a massive £25bn impairment charge.

Nokia slipped again, falling 6%, following news that U.S. telecom giant AT&T will partner with Ericsson on the rollout of a next-generation wireless network.

Holiday giant Tui was on the rise after bumper profits and a forecast 25% rise in operating earnings this year, while Hello Fresh and Delivery Hero also gained after being named the top picks of internet stocks by JP Morgan.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Broker tips: FRP Advisory, AutoTrader
(Sharecast News) - Analysts at Berenberg raised their target price on liquidators FRP Advisory from 175.0p to 200.0p on Friday, stating the group's FY24 update delivered "sizeable upgrades".
London close: Stocks recoup some earlier losses
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.
US open: Dow Jones on track for fifth-straight winning week
(Sharecast News) - Wall Street stocks were little changed early on Friday after the blue-chip Dow Jones briefly crossed the psychologically important 40,000-point mark for the first time in its history a day earlier.
FTSE 250 movers: IDS in focus on bid hopes; TUI slips
(Sharecast News) - FTSE 250 (MCX) 20,752.84 -0.34%

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.